DK76578A - Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf

Info

Publication number
DK76578A
DK76578A DK76578A DK76578A DK76578A DK 76578 A DK76578 A DK 76578A DK 76578 A DK76578 A DK 76578A DK 76578 A DK76578 A DK 76578A DK 76578 A DK76578 A DK 76578A
Authority
DK
Denmark
Prior art keywords
salts
procedure
preparation
methyltetrahydrofolic acid
methyltetrahydrofolic
Prior art date
Application number
DK76578A
Other languages
English (en)
Other versions
DK144944C (da
DK144944B (da
Inventor
F Gennari
Original Assignee
Bioresearch Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Sas filed Critical Bioresearch Sas
Publication of DK76578A publication Critical patent/DK76578A/da
Publication of DK144944B publication Critical patent/DK144944B/da
Application granted granted Critical
Publication of DK144944C publication Critical patent/DK144944C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK76578A 1977-02-22 1978-02-21 Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf DK144944C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB729077 1977-02-22
GB7290/77A GB1572137A (en) 1977-02-22 1977-02-22 Stable compositions for therapeutic use based on d,1-5-methyltetrahydrofolic acid and its salts

Publications (3)

Publication Number Publication Date
DK76578A true DK76578A (da) 1978-08-23
DK144944B DK144944B (da) 1982-07-12
DK144944C DK144944C (da) 1982-11-29

Family

ID=9830275

Family Applications (1)

Application Number Title Priority Date Filing Date
DK76578A DK144944C (da) 1977-02-22 1978-02-21 Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf

Country Status (32)

Country Link
JP (1) JPS5831353B2 (da)
AR (1) AR215162A1 (da)
AT (1) AT380020B (da)
AU (1) AU520715B2 (da)
BE (1) BE863808A (da)
CA (1) CA1093554A (da)
CH (1) CH635344A5 (da)
CZ (1) CZ279815B6 (da)
DD (1) DD134099A5 (da)
DE (1) DE2807393A1 (da)
DK (1) DK144944C (da)
EG (1) EG13399A (da)
ES (1) ES467153A1 (da)
FI (1) FI67082C (da)
FR (2) FR2381047A1 (da)
GB (1) GB1572137A (da)
GR (1) GR71704B (da)
HU (1) HU179422B (da)
IE (1) IE46402B1 (da)
IL (1) IL54052A (da)
IN (1) IN149574B (da)
LU (1) LU79067A1 (da)
MX (1) MX5288E (da)
NL (1) NL190285C (da)
NO (1) NO147793C (da)
NZ (1) NZ186465A (da)
PL (1) PL118654B1 (da)
PT (1) PT67656B (da)
SE (1) SE437028B (da)
SU (1) SU747427A3 (da)
YU (1) YU40505B (da)
ZA (1) ZA78837B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5838285A (ja) * 1981-08-25 1983-03-05 Kanegafuchi Chem Ind Co Ltd 5−メチル−(6rs)−5,6,7,8−テトラヒドロ−l−葉酸のマグネシウム塩またはその遊離酸の製法
GB8621268D0 (en) * 1986-09-03 1986-10-08 Univ Strathclyde Separation of substances
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
NL8901432A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
CH680731A5 (da) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
US5217974A (en) * 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
CH683261A5 (it) * 1991-10-10 1994-02-15 Applied Pharma Res Procedimento per la preparazione dell'acido metiltetraidrofolico nella forma (6(R,S)(-))N-5 e separazione del diastereoisomero attivo (6(S)(-))N-5) sotto forma di sali.
CH682665A5 (de) * 1991-10-29 1993-10-29 Sapec Fine Chemicals Verfahren zur Reinigung von rohen Erdalkalimetallsalzen von N(5)-Methyl-5,6,7,8-tetrahydrofolsäure.
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH698729B1 (de) * 2007-05-30 2009-10-15 Cerbios Pharma Sa Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure.
CN103214487A (zh) * 2013-04-12 2013-07-24 张家港威胜生物医药有限公司 一种重要医药化工原料(6s)-5-甲基四氢叶酸盐的合成
WO2015193778A1 (en) 2014-06-16 2015-12-23 Mylan Laboratories Ltd. Crystalline form of levomefolate calcium
US20210324176A1 (en) 2018-08-28 2021-10-21 Pmc Organometallix, Inc. Low free 2-mercaptoethanol ester and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL80276C (da) *
GB1293541A (en) * 1969-03-18 1972-10-18 John Alexander Blair Folic acid derivatives
US3856959A (en) * 1972-07-24 1974-12-24 Department Of Health Education Inhibition of leukemia utilizing 5-methyltetrahydrohomofolate
US4148999A (en) * 1977-08-22 1979-04-10 The Government Of The United States Of America Preparation and purification of citrovorum factor
CH649550A5 (en) * 1984-02-09 1985-05-31 Eprova Ag Process for the preparation of alkaline earth metal salts of 5-methyltetrahydrofolic acid

Also Published As

Publication number Publication date
FR2381047A1 (fr) 1978-09-15
PT67656A (en) 1978-03-01
FI67082B (fi) 1984-09-28
ES467153A1 (es) 1978-11-16
BE863808A (fr) 1978-05-29
NL7801775A (nl) 1978-08-24
AU3343078A (en) 1979-08-30
DK144944C (da) 1982-11-29
IN149574B (da) 1982-01-30
IE46402B1 (en) 1983-06-01
IL54052A0 (en) 1978-04-30
DE2807393C2 (da) 1990-06-13
MX5288E (es) 1983-06-06
DD134099A5 (de) 1979-02-07
PL204747A1 (pl) 1979-03-12
SE437028B (sv) 1985-02-04
IL54052A (en) 1981-07-31
CZ112978A3 (en) 1995-02-15
NL190285B (nl) 1993-08-02
NO147793C (no) 1983-06-15
DE2807393A1 (de) 1978-09-07
SE7801973L (sv) 1978-08-23
CA1093554A (en) 1981-01-13
FI67082C (fi) 1985-01-10
FR2385397B1 (da) 1981-07-17
CH635344A5 (en) 1983-03-31
CZ279815B6 (cs) 1995-07-12
DK144944B (da) 1982-07-12
YU37978A (en) 1983-01-21
NL190285C (nl) 1994-01-03
JPS5831353B2 (ja) 1983-07-05
NZ186465A (en) 1980-10-08
FI780565A (fi) 1978-08-23
HU179422B (en) 1982-10-28
GR71704B (da) 1983-06-21
GB1572137A (en) 1980-07-23
ZA78837B (en) 1979-09-26
AT380020B (de) 1986-03-25
PT67656B (en) 1979-07-19
SU747427A3 (ru) 1980-07-23
AU520715B2 (en) 1982-02-25
EG13399A (en) 1981-12-31
JPS53124297A (en) 1978-10-30
ATA90378A (de) 1985-08-15
NO147793B (no) 1983-03-07
PL118654B1 (en) 1981-10-31
FR2385397A1 (fr) 1978-10-27
YU40505B (en) 1986-02-28
LU79067A1 (fr) 1978-06-27
NO780594L (no) 1978-08-23
IE780285L (en) 1978-08-22
FR2381047B1 (da) 1981-07-24
AR215162A1 (es) 1979-09-14

Similar Documents

Publication Publication Date Title
DK499778A (da) Fremgangsmaade til fremstilling af 9-(omegaheteroarylamino-alkylamino)-erythromyciner eller salte deraf
DK56077A (da) Fremgangsmade til fremstilling af 3-quinolincarboxylsyrederivater eller additionssalte deraf
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK392877A (da) Fremgangsmaade til fremstilling af phenylethylaminer eller syreadditionssalte heraf
DK273479A (da) Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK76578A (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK118578A (da) Fr&mgangsmaade til fremstilling af pyridinylaminoalkylethere,n-oxider eller physiologisk acceptable syreadditionssalte deraf
DK27078A (da) Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf
DK158977C (da) Fremgangsmaade til fremstilling af substituerede guanidiner eller salte deraf
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK511878A (da) Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf
DK20077A (da) Fremgangsmade til fremstilling af salte af 3,3-dimethyl-2-oxo-smorsyre
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK152042C (da) Analogifremgangsmaader til fremstilling af n-cycloalkylmethyl-2-phenyl-aminoimidazolin-forbindelser eller syreadditionssalte deraf
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK127676A (da) Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf
DK146540C (da) Fremgangsmaade til fremstilling af alkaloider af leurosin-typen, eller syreadditionssalte deraf
DK115379A (da) Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK491678A (da) Fremgangsmaade til fremstilling af arylaetere af n-alkylpiperidiner eller syreadditionssalte deraf

Legal Events

Date Code Title Description
PUP Patent expired